Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same?: A prospective study

Atherosclerosis

Volumn 148, Issue 1, 2000, Pages 159-169

  Forrest, Kimberly Y Z ^c   Becker, Dorothy J ^a   Kuller, Lewis H ^a   Wolfson, Sidney K ^b   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Univ of Pittsburgh Sch of Med ^*

Author keywords

Coronary heart disease; Glycemic control; Lower extremity arterial disease; Risk factors; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ARTERIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; FORECASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; LEG; MALE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 0033990538     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00217-8     Document Type: Article

References (56)

1. Donahue R.P., Orchard T.J. Diabetes mellitus and macrovascular complications: an epidemiologic perspective. Diabetes Care. 15:1992;1141-1155.
2. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C. et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol. 59:1987;750-755.
3. Maser R.E., Wolfson S.K., Stein E.A., Drash A.L., Becker D.J., Dorman J.S. et al. Cardiovascular disease and arterial calcification in insulin dependent diabetes mellitus: interrelationships and risk factor profiles: Pittsburgh Epidemiology of Diabetes Complications Study-VI. Arterioscler. Thromb. 11:1991;958-965.
4. Lloyd C.E., Kuller L.H., Becker D.J., Ellis D., Wing R.R., Orchard T.J. Coronary artery disease in IDDM: gender differences in risk factors, but not risk. Arterioscler. Throm. Vasc. Biol. 16:1996;720-726.
5. Koivisto V.A., Stevens L.K., Mattock M.B., Ebeling P., Stephenson J., Idzior-Walus B. EURODIAB IDDM Complications Study Group: cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 19:1996;689-697.
6. Albrink M.J., Lavietes P.H., Man E.B. Vascular disease and serum lipids in diabetes mellitus. Ann. Intern. Med. 58:1963;305-323.
7. Santen R.J., Willis P.W.-III, Fajans S.S. Atherosclerosis in diabetes mellitus: correlations with serum lipid levels, adiposity, and serum insulin level. Arch. Intern. Med. 130:1972;833-843.
8. West K.M., Ahuja M.M.S., Bennett P.H., Czyzyk A., De Acosta O.M., Fuller J.H. et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 6:1983;361-369.
9. Orchard T.J. Dyslipoproteinemia and diabetes. Endocrinology and Metabolism Clinics of North America. 19:1990;361-380.
10. Laakso M., Rönnemaa T., Pyörälä K., Kallio V., Puukka P., Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 11:1988;449-463.
11. Barrett-Connor E, Orchard TJ. Diabetes and heart disease. In: Diabetes in America. Washington DC: National Diabetes Data group, 1985:1-41.
12. Christlieb A.R., Warram J.H., Krolewski A.S., Busick E.J., Ganda O.P., Asmal A.C. et al. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes. 30:1981;90-96.
13. Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ. 294:1987;1651-1654.
14. Lloyd C.E., Becker D.J., Wolfson S.K., Ellis D., Orchard T.J. The incidence of complications in insulin-dependent diabetes mellitus; a survival analysis. Am. J. Epidemiol. 143:1996;431-441.
15. Orchard T.J., Forrest K.Y.-Z., Ellis D., Becker D.J. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. Arch. Intern. Med. 157:1997;1851-1856.
16. Wagener D.K., Sacks J.M., LaPorte R.E., MacGregor J.M. The Pittsburgh Study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes. 31:1982;136-144.
17. Orchard T.J., Dorman J.S., Maser R.E., Becker D.J., Drash A.L., Ellis D. et al. The prevalence of complications in insulin dependent diabetes mellitus by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study-II. Diabetes. 39:1990;1116-1124.
18. Orchard T.J., Dorman J.S., Maser R.E., Becker D.J., Ellis D., LaPorte R.E. et al. Factors associated with the avoidance of severe complications after 25 years of insulin dependent diabetes mellitus: Pittsburgh Epidemiology of Diabetes Complications Study-I. Diabetes Care. 13:1990;741-747.
19. Beck A.T., Garbin M.G. Psychometric properties of the Beck depression inventory: 25 years of evaluation. Clin. Psychol. 8:1988;77-100.
20. Kriska A.M., LaPorte R.E., Patrick S.L., Kuller L.H., Orchard T.J. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: The Epidemiology of Diabetes Complications Study-VII. J. Clin. Epidemiol. 44:1991;1207-1214.
21. Borhani N.O., Kass E.H., Langford H.G., Payne G.H., Remington R.D., Stamler J. The hypertension detection and follow-up program. Prev. Med. 5:1976;207-215.
22. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20:1974;470-475.
23. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19:1973;476-482.
24. Warnick G.R., Albers J.J. Heparin-Mn2+ quantitaion of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin. Chem. 24:1978;900-904.
25. National Institutes of Health, Dept. of Health. Lipid Research Clinics Program. 1975; 75-628. Washington, DC, US Government Printing Office.
26. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
27. Mendoza S.G., Zerpa A., Carrassco H., Colmenares O., Rangel A., Gartside P.S., Kashyap M.L. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 12:1983;1-23.
28. Stein EA, Pesce JA. Enzyme-linked immunoassays for apolipoproteins: advantages, problems, and prototype assay. 1983; 83-1266. Washington, DC US Dept. of Health and Human Services.
29. Paffenbarger R.S., Wing A.L., Hyde R.T. Physical activity as an index of heart attack risk in college alumni. Am. J. Epidemiol. 108:1978;161-175.
30. Orchard TJ, CCSP. Validation of coronary heart disease mortality data: the Community Cardiovascular Surveilance Project Pilot. American Heart Association Cardiovascular Disease Epidemiology Newsletter 1985; 46 Abstract.
31. Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Avner ED, Orchard TJ. Choice of urine predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus, Am. J. Kidney Dis. 1989; XIII:321-328.
32. Ellis D., Buffone G.J. New approach to evaluation of proteinuric states. Clin. Chem. 23:1977;666-670.
33. Kuller L.H., Shemanski L., Psaty B.M., Borhani N.O., Gardin J., Haan M.N. et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 92:1995;720-726.
34. Chambless L.E., Heiss G., Folsom A.R., Rosamond W., Szklo M., Sharrett A.R. et al. Association of coronary heart disease indicence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am. J. Epidemiol. 146:1997;483-494.
35. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann R.J. et al. Mortality over 10 years in patients with peripheral arterial disease. New Eng. J. Med. 326:1992;381-386.
36. Orchard T.J., Strandness D.E.-J.r Assessment of peripheral vascular disease in diabetes. Report and recommendations of an International Workshop sponsored by the AHA and the ADA. Diabetes Care. 16:1993;1199-1209.
37. Seltzer H.S. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP). Diabetes. 21:1972;976-979.
38. Abraira C., Colwell J.A., Nuttall F.Q., Sawin C.T., Nagel N.J., Comstock J.P. Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care. 18:1995;1113-1123.
39. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with convential treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-852.
40. Bucala R., Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis. 26:1995;875-888.
41. Clemmons D.R. Role of peptide growth factors in development of macrovascular complications of diabetes. Diabetes Care. 14:1991;153-156.
42. Katsilambros NL, Tsapogas PC, Arvanitis MP, Tritos NA, Alexiou AP, Rigas KL. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons, Diabetic Med 1996; (13)243-246.
43. Abate N. Insulin resistance and obesity: the role of fat distribution pattern. Diabetes Care. 19:1996;292.
44. Bjorntop P. Visceral fat accumulation:the missing link between psychosocial factors and cardiovascular disease? J. Intern. Med. 230:1998;195-201.
45. Sweetnam P.M., Thomas H.F., Yarnell J.W.G., Baker I.A., Elwood P.C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell Studies. Am. J. Epidemiol. 5:1998;416-421.
46. Janka J.U. Five-year incidence of major microvascular complications in several different studies. Horm. Metab. Res. Suppl. 15:1984;15-19.
47. Nelson R.G., Sievers M.L., Knowler W.C., Swinburn B.A., Pettitt D.J., Saad M.F. et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation. 81:1990;987-995.
48. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
49. Laakso M., Pyorala K. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis. 74:1998;55-63.
50. Igau B., Lestavel S., Clavey V., Slomianny C., Drouin P., Bresson R. ApoB containing lipoprotein particles in poorly controlled insulin-dependent diabetes. Atherosclerosis. 120:1996;209-219.
51. Sweetnam P.M., Thomas H.F., Yarnell J.W.G., Beswick A.D., Baker I.A., Elwood P.C. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease-the Caerphilly and Speedwell studies. Eur. Heart J. 17:1996;1814-1820.
52. Medalie J.H. Risk factors other than hyperglycemia in diabetic macrovascular disease. Diabetes Care. 2:1979;77-84.
53. Eastman R.C., Javitt J.C., Herman W.H., Dasbach E.J., Zbrozek A.S., Manninen D. et al. Model of complications of NIDDM: 1. Model construction and assumptions. Diabetes Care. 20:1997;725-734.
54. Beach K., Strandness D.E. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin dependent diabetes. Diabetes. 29:1980;882-888.
55. Vogt M.T., Cauley J.A., Kuller L.H., Hulley S.B. Prevalence and correlated of lower extremity arterial disease in elderly women. Am. J. Epidemiol. 137:1993;559-568.
56. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, VanPatten S. Tobacco smoke is a source of toxic reactive glycation products. Proceedings of the National Academy of Science of the USA 1997; 94:(25)13915-13920.